XML 77 R54.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Collaborative Research, Development and License Agreements - Additional Information (Detail) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | ---
Nov. 30, 2016 | Jun. 30, 2007 | Mar. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2016 | Dec. 31, 2015 | Dec. 31, 2017 | Nov. 30, 2017
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |
Liability related to unused development funding |  |  |  | $ 11,192,000 | $ 11,192,000 |  | $ 9,695,000 |
Maximum |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |
Additional milestone payments eligible to be received based on achievement of certain development and regulatory objectives |  |  |  |  |  |  | 100,000,000 |
Astra Zeneca |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |
Milestone payments earned | $ 7,200,000 |  |  |  | 7,200,000 |  |  |
Unused development funding advanced by AstraZeneca | $ 7,400,000 |  |  |  |  |  |  |
Milestone revenue recognition |  |  |  | $ 7,200,000 | $ 103,000 | $ 1,635,000 |  |
Unused development funding paid |  |  | $ 200,000 |  |  |  |  |
Liability related to unused development funding |  |  |  |  |  |  | 0 |
Coley Pharmaceutical Group, Inc. |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |
Intangible asset |  |  |  |  |  |  |  | $ 2,500,000
Agreement termination date |  | 2018-02 |  |  |  |  |  |
Expected milestone payments prior to termination |  |  |  |  |  |  | 0 |
Coley Pharmaceutical Group, Inc. | Accounts Payable |  |  |  |  |  |  |  |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] |  |  |  |  |  |  |  |
Payment due included in accounts payable |  |  |  |  |  |  | $ 2,500,000 |

X
- Definition Accrued return of unused development funding to affiliate current. + References No definition available. + Details
Name: | dvax_AccruedReturnOfUnusedDevelopmentFundingToAffiliateCurrent
Namespace Prefix: | dvax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Agreement termination period month and year. + References No definition available. + Details
Name: | dvax_AgreementTerminationPeriodMonthAndYear
Namespace Prefix: | dvax_
Data Type: | xbrli:gYearMonthItemType
Balance Type: | na
Period Type: | duration

X
- Definition Collaborative arrangement additional milestone payment to be received on achievement of certain objectives. + References No definition available. + Details
Name: | dvax_CollaborativeArrangementAdditionalMilestonePaymentToBeReceivedOnAchievementOfCertainObjectives
Namespace Prefix: | dvax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Expected milestone payments prior to termination of agreement. + References No definition available. + Details
Name: | dvax_ExpectedMilestonePaymentsPriorToTerminationOfAgreement
Namespace Prefix: | dvax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Payment of unused development funding to affiliate. + References No definition available. + Details
Name: | dvax_PaymentOfUnusedDevelopmentFundingToAffiliate
Namespace Prefix: | dvax_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Proceeds from milestone payment. + References No definition available. + Details
Name: | dvax_ProceedsFromMilestonePayment
Namespace Prefix: | dvax_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_AccruedLiabilitiesCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments. + References No definition available. + Details
Name: | us-gaap_ContractualObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount before accumulated amortization of intangible assets, excluding goodwill. + References No definition available. + Details
Name: | us-gaap_IntangibleAssetsGrossExcludingGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of consideration recognized during the period for the milestone or milestones. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 28 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=68058744&loc=SL6892177-166501 + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=dvax_AstraZenecaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=dvax_ColeyPharmaceuticalGroupIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |